𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients

✍ Scribed by Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida

Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
94 KB
Volume
98
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

CyclinD1 plays a critical role in regulating cell cycle progression. CyclinD1 mRNA and protein are overexpressed in approximately 50% of primary breast cancer cases. However, its clinical significance as a predictive factor remains unclear. One hundred and seventy‐three female patients diagnosed with invasive ductal carcinoma who had undergone a mastectomy (161 patients) or breast‐conserving surgery (12 patients) were followed up for 6–119 months (median 86 months) postoperatively. Immunoreactivity for monoclonal anti‐cyclinD1 antibody (clone DCS‐6) with paraffin‐embedded carcinoma tissues was investigated using a labeled streptavidin‐biotin method. Overexpression of cyclinD1 was found in 42% (73 of 173), and strongly correlated with estrogen receptor (ER) expression (p < 0.000001). Univariate analysis revealed no association between overexpression of cyclinD1 and overall survival or relapse‐free survival in all patient groups. However, in the ER‐negative subgroup (n = 75), overexpression of cyclinD1 was significantly correlated with shorter overall survival (p = 0.018) and relapse‐free survival (p = 0.014) as well as the lymph node status and tumor size. In contrast, there were no significant associations between overexpression of cyclinD1 and clinical outcome in the ER‐positive subgroup. According to Cox's multivariate analysis in the ER‐negative subgroup, overexpression of cyclinD1 had the most significant effect on overall survival (p = 0.02) and relapse‐free survival (p = 0.0058), followed by nodal status and histologic grade. These findings suggest that overexpression of cyclinD1 is an independent prognostic indicator in ER‐negative breast cancer patients. © 2002 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Expression of maspin predicts poor progn
Expression of maspin predicts poor prognosis in breast-cancer patients
✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 365 KB

## Abstract The tumor suppressor gene __maspin__ has been reported to inhibit the invasiveness and motility of breast cancer cells. It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin

Detection of breast cancer cells in the
Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis
✍ José-Juan Gaforio; María-José Serrano; Pedro Sanchez-Rovira; Antonio Sirvent; Mi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB

## Abstract We investigated whether detection of cytokeratin‐positive (CK+) cells in the peripheral blood (PB) of breast cancer patients before chemotherapy could be a prognostic factor. Blood from a total of 92 breast cancer patients was evaluated for the presence of CK+ cells. Blood samples were

High expression of leptin receptor mRNA
High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels
✍ Yasuo Miyoshi; Tohru Funahashi; Sachiyo Tanaka; Tetsuya Taguchi; Yasuhiro Tamaki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 330 KB

The association of mRNA expression levels of leptin receptors (long isoform: Lep-R(L) and short isoform: Lep-R(S)) in breast cancer tissue with patient prognosis was studied with special reference to the serum leptin level or the leptin mRNA level in tumor tissue. Lep-R(L), Lep-R(S) and leptin mRNA

Decreased immunoreactivity for p27 prote
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V
✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m